For 21-year-vintage Kaha Kelau, a brief trip from Hawaii to Arizona to study mechanics was meant to be a stepping stone toward a career. Instead, it became the catalyst for a medical crisis that nearly cost him his life. After returning home to Hawaii, Kelau began experiencing severe headaches and neck pain—symptoms that seemed manageable at first but rapidly spiraled into a paralyzing illness.
The diagnosis was a harrowing one: Valley fever that had disseminated from his lungs to his brain. This rare progression of the disease, known as fungal meningitis, left the student fighting for his life in an intensive care unit, suffering through seizures and a stroke. His story highlights the perilous nature of Valley fever: Student diagnosed with rare disease fighting for his life, and the critical importance of geographic history in medical diagnostics.
Kelau’s family describes a terrifying period of uncertainty where the cause of his decline remained a mystery. “This started as just a headache, no cough, no fever no signs that nothing else was wrong,” his mother, Laura, said. Because the illness manifested after he had already left the Southwestern United States, the infection was not initially suspected by local providers.
“Never even heard of valley fever before getting a diagnosis of it,” Laura said. “They weren’t even looking for valley fever. It wasn’t on anyone’s radar.”
The Path from Inhalation to Infection
Valley fever, or coccidioidomycosis, is caused by the fungus Coccidioides, which lives in the soil of arid regions like Arizona, and California. The infection begins when a person inhales fungal spores disturbed by wind or construction. Even as most healthy individuals either demonstrate no symptoms or experience a flu-like illness, a small percentage of patients develop a disseminated infection.
In these rare cases, the fungus escapes the lungs and travels through the bloodstream to other organs. When it reaches the central nervous system, it causes fungal meningitis, a life-threatening condition that triggers inflammation and swelling of the brain. For Kelau, the result was catastrophic: he suffered several seizures and a small stroke, necessitating an induced coma to manage the intracranial pressure.
Because of the complexity of his condition, Kelau was airlifted to the Mayo Clinic. According to the family’s GoFundMe page, the facility was the only location equipped to perform the specialized procedure of injecting anti-fungal medication directly into his brain to combat the infection at its source.
| Phase | Key Events |
|---|---|
| Exposure | Travels from Hawaii to Arizona for mechanics school. |
| Onset | Returns to Hawaii; develops worsening headaches and neck pain. |
| Diagnosis | Following months of testing, diagnosed with disseminated Valley fever. |
| Acute Care | Airlifted to Mayo Clinic; treated for seizures and stroke via induced coma. |
| Recovery | Spends 136 days in the ICU; begins relearning motor skills. |
The Challenge of Geographic Blind Spots
The delay in Kelau’s diagnosis underscores a recurring problem in public health: the “geographic blind spot.” Physicians in regions where Valley fever is not endemic, such as Hawaii, may not include it in their differential diagnosis, even when a patient has a history of travel to the Southwest. This can lead to months of ineffective testing while the fungus continues to damage the nervous system.
Medical professionals at the Mayo Clinic noted that Kelau’s case mirrored others they have treated where spores successfully breached the blood-brain barrier. The difficulty in diagnosing these cases often stems from the fact that the initial respiratory symptoms—cough or fever—may be absent or mild, as was the case with Kelau.
To address this gap, researchers are working to modernize how the disease is detected. Dr. Thomas Grys is currently finalizing the world’s first rapid blood test for Valley fever, which is expected to be released later this year. Such a tool could drastically reduce the time between the onset of symptoms and the start of life-saving antifungal therapy, potentially preventing the neurological devastation seen in disseminated cases.
A Grueling Road to Recovery
After spending 136 days in the intensive care unit, Kaha Kelau is now engaged in the slow, painstaking process of neurological rehabilitation. The damage from the stroke and the prolonged coma means he must relearn basic movements and communication.
Despite the severity of the brain injury, Notice signs of progress. Dr. Marie Grill noted that Kelau has begun to follow some commands. In one emotional milestone, he was able to spell out, “I love you mom,” to his mother. “Those are really remarkable steps,” Dr. Grill said.
The emotional toll on the family has been immense, with Laura noting that doctors had frequently prepared them for the worst. However, she says her son’s resilience has turn into the family’s primary source of strength. “The strength that this kid has is just amazing,” she said. “On days when I want to give up, I can’t, because I look at him and I spot him continuing to fight.”
The financial burden of such a prolonged ICU stay and specialized care at a facility like the Mayo Clinic is staggering. The family has established a GoFundMe to help cover mounting medical bills and the costs associated with travel and long-term recovery.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
As Dr. Grys moves toward the release of the rapid diagnostic test, the medical community hopes that cases like Kaha’s will become rarer. The next major milestone for the family is the continued progression of Kelau’s physical therapy as he works to regain independence.
We invite readers to share their thoughts or experiences with rare infections in the comments below.
